Sat 12/16/2017 09:45 ET
DJIA24651.74143.080.58%SOLAR24.530.050.20%GOLD1258.201.130.09%Shanghai3136.7734.501.10%
S&P 5002675.8123.810.89%BANKS27.810.381.37%OIL57.340.300.52%Nikkei22420.08417.011.86%
NASDAQ6936.5879.771.15%SEMI99.251.601.61%US/EU1.180.000.17%Futures2682.0026.000.97%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Penny Stocks (CHINESEINVESTORSCOM - CIIX)   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add CIIX
  
From: NetworkNewsWire (Rep: 0)Date: 12/05/2017 18:21
Forum: Penny Stocks - Msg #1010 - List CIIX msgs Thread #673971188 (Rec: 0)
ChineseInvestors.com, Inc. (CIIX) Partners with Global E-commerce Behemoths

- Alibaba and Amazon dominate global e-commerce
- ChineseInvestors.com just successfully launched first hemp-infused skin care products in China
- Company aims to dominate market

When considering e-commerce, Amazon is usually the first name that pops up. However, Alibaba is, by many metrics, both China’s and the world’s largest online e-commerce company. Alibaba commands about 50% market share of business-to-consumer e-commerce in China, while Amazon is the e-commerce elephant in the United States, garnering about 44% of e-commerce sales. To achieve maximum market penetration and global exposure, ChineseInvestors.com, Inc. (OTCQB: CIIX) just successfully launched its OptHemp Product Line on both Amazon and Alibaba.

Initially launched as a specialized investment services company providing real-time commentary, analysis and educational related services in the Chinese language, ChineseInvestors.com’s long-term quest for value-add opportunities led it to stake out a position in the explosive new medical CBD market. With nearly two decades of brand recognition, a 100,000+ user base and a target market of nearly two billion Chinese-speaking people, ChineseInvestors.com launched into the CBD market in 2016. Simultaneously, the company continued to expand its core investor education business, adding a Chinese speakers-targeted daily video telecast on cryptocurrencies, and recently announce a 186 percent jump in sales for 1Q2018 in its investor relations division.

In addition to nurturing its legacy business to record growth, ChineseInvestors.com has established a significant footprint in the global CBD market in only one year. The company’s latest foray into the CBD market may be its boldest and, potentially, most profitable endeavor to date, as it aims to dominate the entire hemp-infused skin care products market throughout China. The company retails its hemp oil-based cannabidiol (CBD) products on Alibaba and Amazon under the “OptHemp” brand through its wholly-owned subsidiaries, CBD Biotechnology Co. Ltd. and ChineseHempOil.com, Inc. As indication of consumer acceptance, the company’s “CBD Magic Hemp Series” generated 40,000 views and registered over 91 units purchased just minutes after launch. Commenting on the overwhelming response to its product launch, ChineseInvestors.com CEO Warren Wang stated that it “solidifies our belief that Chinese consumers recognize that the anti-inflammatory agents and anti-oxidants contained in hemp-extract can have positive effects on the skin.”

In business for nearly two decades and with a track record of stellar revenue growth and strategic diversification, the company is primed to capitalize on its position as the first to market in China with hemp-infused skin care products through its partnerships with global e-commerce behemoths. These factors certainly suggest strong upside potential for ChineseInvestors.com.

For more information, visit the company’s website at www.ChineseInvestors.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser NetworkNewsWire: Reward | Watch | IgnoreCIIX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add CIIX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.